267 related articles for article (PubMed ID: 30693017)
1. RNA Polymerase II-Dependent Transcription Initiated by Selectivity Factor 1: A Central Mechanism Used by MLL Fusion Proteins in Leukemic Transformation.
Yokoyama A
Front Genet; 2018; 9():722. PubMed ID: 30693017
[TBL] [Abstract][Full Text] [Related]
2. AF4 uses the SL1 components of RNAP1 machinery to initiate MLL fusion- and AEP-dependent transcription.
Okuda H; Kanai A; Ito S; Matsui H; Yokoyama A
Nat Commun; 2015 Nov; 6():8869. PubMed ID: 26593443
[TBL] [Abstract][Full Text] [Related]
3. TBP loading by AF4 through SL1 is the major rate-limiting step in MLL fusion-dependent transcription.
Okuda H; Takahashi S; Takaori-Kondo A; Yokoyama A
Cell Cycle; 2016 Oct; 15(20):2712-22. PubMed ID: 27564129
[TBL] [Abstract][Full Text] [Related]
4. Activation of CpG-Rich Promoters Mediated by MLL Drives MOZ-Rearranged Leukemia.
Miyamoto R; Okuda H; Kanai A; Takahashi S; Kawamura T; Matsui H; Kitamura T; Kitabayashi I; Inaba T; Yokoyama A
Cell Rep; 2020 Sep; 32(13):108200. PubMed ID: 32997997
[TBL] [Abstract][Full Text] [Related]
5. Cooperative gene activation by AF4 and DOT1L drives MLL-rearranged leukemia.
Okuda H; Stanojevic B; Kanai A; Kawamura T; Takahashi S; Matsui H; Takaori-Kondo A; Yokoyama A
J Clin Invest; 2017 May; 127(5):1918-1931. PubMed ID: 28394257
[TBL] [Abstract][Full Text] [Related]
6. Leukemogenesis via aberrant self-renewal by the MLL/AEP-mediated transcriptional activation system.
Yokoyama A
Cancer Sci; 2021 Oct; 112(10):3935-3944. PubMed ID: 34251718
[TBL] [Abstract][Full Text] [Related]
7. A higher-order complex containing AF4 and ENL family proteins with P-TEFb facilitates oncogenic and physiologic MLL-dependent transcription.
Yokoyama A; Lin M; Naresh A; Kitabayashi I; Cleary ML
Cancer Cell; 2010 Feb; 17(2):198-212. PubMed ID: 20153263
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional activation by MLL fusion proteins in leukemogenesis.
Yokoyama A
Exp Hematol; 2017 Feb; 46():21-30. PubMed ID: 27865805
[TBL] [Abstract][Full Text] [Related]
9. HBO1-MLL interaction promotes AF4/ENL/P-TEFb-mediated leukemogenesis.
Takahashi S; Kanai A; Okuda H; Miyamoto R; Komata Y; Kawamura T; Matsui H; Inaba T; Takaori-Kondo A; Yokoyama A
Elife; 2021 Aug; 10():. PubMed ID: 34431785
[TBL] [Abstract][Full Text] [Related]
10. The mixed-lineage leukemia fusion partner AF4 stimulates RNA polymerase II transcriptional elongation and mediates coordinated chromatin remodeling.
Bitoun E; Oliver PL; Davies KE
Hum Mol Genet; 2007 Jan; 16(1):92-106. PubMed ID: 17135274
[TBL] [Abstract][Full Text] [Related]
11. [The mechanism of MLL-rearranged leukemogenesis and its targeted therapies].
Yokoyama A
Rinsho Ketsueki; 2021; 62(8):988-997. PubMed ID: 34497239
[TBL] [Abstract][Full Text] [Related]
12. Small-molecule inhibitor of AF9/ENL-DOT1L/AF4/AFF4 interactions suppresses malignant gene expression and tumor growth.
Wu F; Nie S; Yao Y; Huo T; Li X; Wu X; Zhao J; Lin YL; Zhang Y; Mo Q; Song Y
Theranostics; 2021; 11(17):8172-8184. PubMed ID: 34373735
[TBL] [Abstract][Full Text] [Related]
13. A role for the MLL fusion partner ENL in transcriptional elongation and chromatin modification.
Mueller D; Bach C; Zeisig D; Garcia-Cuellar MP; Monroe S; Sreekumar A; Zhou R; Nesvizhskii A; Chinnaiyan A; Hess JL; Slany RK
Blood; 2007 Dec; 110(13):4445-54. PubMed ID: 17855633
[TBL] [Abstract][Full Text] [Related]
14. MLL fusion proteins link transcriptional coactivators to previously active CpG-rich promoters.
Okuda H; Kawaguchi M; Kanai A; Matsui H; Kawamura T; Inaba T; Kitabayashi I; Yokoyama A
Nucleic Acids Res; 2014 Apr; 42(7):4241-56. PubMed ID: 24465000
[TBL] [Abstract][Full Text] [Related]
15. Leukemogenic MLL-ENL Fusions Induce Alternative Chromatin States to Drive a Functionally Dichotomous Group of Target Genes.
Garcia-Cuellar MP; Büttner C; Bartenhagen C; Dugas M; Slany RK
Cell Rep; 2016 Apr; 15(2):310-22. PubMed ID: 27050521
[TBL] [Abstract][Full Text] [Related]
16. Human Polymerase-Associated Factor complex (PAFc) connects the Super Elongation Complex (SEC) to RNA polymerase II on chromatin.
He N; Chan CK; Sobhian B; Chou S; Xue Y; Liu M; Alber T; Benkirane M; Zhou Q
Proc Natl Acad Sci U S A; 2011 Sep; 108(36):E636-45. PubMed ID: 21873227
[TBL] [Abstract][Full Text] [Related]
17. The eleven-nineteen-leukemia protein ENL connects nuclear MLL fusion partners with chromatin.
Zeisig DT; Bittner CB; Zeisig BB; García-Cuéllar MP; Hess JL; Slany RK
Oncogene; 2005 Aug; 24(35):5525-32. PubMed ID: 15856011
[TBL] [Abstract][Full Text] [Related]
18. The elongation domain of ELL is dispensable but its ELL-associated factor 1 interaction domain is essential for MLL-ELL-induced leukemogenesis.
Luo RT; Lavau C; Du C; Simone F; Polak PE; Kawamata S; Thirman MJ
Mol Cell Biol; 2001 Aug; 21(16):5678-87. PubMed ID: 11463848
[TBL] [Abstract][Full Text] [Related]
19. The leukemogenic AF4-MLL fusion protein causes P-TEFb kinase activation and altered epigenetic signatures.
Benedikt A; Baltruschat S; Scholz B; Bursen A; Arrey TN; Meyer B; Varagnolo L; Müller AM; Karas M; Dingermann T; Marschalek R
Leukemia; 2011 Jan; 25(1):135-44. PubMed ID: 21030982
[TBL] [Abstract][Full Text] [Related]
20. Collaboration of MLLT1/ENL, Polycomb and ATM for transcription and genome integrity.
Ui A; Yasui A
Nucleus; 2016 Apr; 7(2):138-45. PubMed ID: 27310306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
